Roche KAPA Target Enrichment Portfolio
Roche launched its new KAPA Target Enrichment product portfolio, which includes both exome and custom target enrichment solutions for sequencing. The KAPA HyperExome is a whole-exome research panel with improved performance compared to the existing SeqCap portfolio that targets the GRCh38/hg38 geome assembly. Roche's HyperDesign tool allows for the creation of custom target enrichment designs using the KAPA HyperChoice probes. The target enrichment portfolio will increase sequencing efficiency, the company said. The new probes replace the discontinued SeqCap product portfolio, although Roche said it will support the discontinued product until the first quarter of 2022.